Related references
Note: Only part of the references are listed.Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Chicoric Acid Induces Apoptosis in 3T3-L1 Preadipocytes through ROS-Mediated PI3K/Akt and MAPK Signaling Pathways
Haifang Xiao et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2013)
Treatment options for advanced pancreatic cancer: a review
Rahma Warsame et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
CXCL12/CXCR4 Protein Signaling Axis Induces Sonic Hedgehog Expression in Pancreatic Cancer Cells via Extracellular Regulated Kinase- and Akt Kinase-mediated Activation of Nuclear Factor κB IMPLICATIONS FOR BIDIRECTIONAL TUMOR-STROMAL INTERACTIONS
Ajay P. Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Time-Dependent Stabilization of Hypoxia Inducible Factor-1α by Different Intracellular Sources of Reactive Oxygen Species
Maura Calvani et al.
PLOS ONE (2012)
β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation
Kyung-Ran Park et al.
CANCER LETTERS (2011)
Overcoming drug resistance in pancreatic cancer
Jiang Long et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Pancreatic cancer: understanding and overcoming chemoresistance
Zhiwei Wang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Honokiol Arrests Cell Cycle, Induces Apoptosis, and Potentiates the Cytotoxic Effect of Gemcitabine in Human Pancreatic Cancer Cells
Sumit Arora et al.
PLOS ONE (2011)
PI3K and ERK-Induced Rac1 Activation Mediates Hypoxia-Induced HIF-1α Expression in MCF-7 Breast Cancer Cells
Jun Du et al.
PLOS ONE (2011)
Tetrandrine down-regulates ERK/NF-κB signaling and inhibits activation of mesangial cells
Chih-Jen Wu et al.
TOXICOLOGY IN VITRO (2011)
Molecular predictors of gemcitabine response in pancreatic cancer
Ioannis A. Voutsadakis
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2011)
CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy
S. Singh et al.
BRITISH JOURNAL OF CANCER (2010)
CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression
Xueqing Sun et al.
CANCER AND METASTASIS REVIEWS (2010)
CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
Beverly A. Teicher et al.
CLINICAL CANCER RESEARCH (2010)
Stabilization of Hypoxia-inducible Factor-1α Protein in Hypoxia Occurs Independently of Mitochondrial Reactive Oxygen Species Production
Yee Liu Chua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
R. Marechal et al.
BRITISH JOURNAL OF CANCER (2009)
Clinical pharmacology and pharmacogenetics of gemcitabine
Andrea Wong et al.
DRUG METABOLISM REVIEWS (2009)
CXCL8/IL-8 and CXCL12/SDF-1α co-operatively promote invasiveness and angiogenesis in pancreatic cancer
Yoichi Matsuo et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Redox regulation of cell survival
Dunyaporn Trachootham et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Regulation of hypoxia-inducible factor-1α by NF-κB
Patrick van Uden et al.
BIOCHEMICAL JOURNAL (2008)
Zerumbone Down-regulates Chemokine Receptor CXCR4 Expression Leading to Inhibition of CXCL12-Induced Invasion of Breast and Pancreatic Tumor Cells
Bokyung Sung et al.
CANCER RESEARCH (2008)
Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells
Seung-Nam Jung et al.
CARCINOGENESIS (2008)
Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer
Jennifer M. Bailey et al.
CLINICAL CANCER RESEARCH (2008)
The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia
R. M. Thomas et al.
GUT (2008)
Osteoblasts-derived TGF-β1 enhance motility and integrin upregulation through Akt, ERK, and NF-κB-dependent pathway in human breast cancer cells
Ying-Ying Wei et al.
MOLECULAR CARCINOGENESIS (2008)
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
Patrick C. Hermann et al.
CELL STEM CELL (2007)
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine
Massimo Donadelli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
YC-1 inhibits HIF-1 expression in prostate cancer cells:: contribution of Akt/NF-κB signaling to HIF-1α accumulation during hypoxia
H-L Sun et al.
ONCOGENE (2007)
Reactive oxygen species activate the HIF-1α promoter via a functional NFκB site
Steve Bonello et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Reactive oxygen species: A breath of life or death?
John P. Fruehauf et al.
CLINICAL CANCER RESEARCH (2007)
Mitogen-activated protein kinases and chemoresistance in pancreatic cancer cells
Yupei Zhao et al.
JOURNAL OF SURGICAL RESEARCH (2006)
The role of PI3K/AKT, MAPK/ERK and NFκβ signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis
Lyle Armstrong et al.
HUMAN MOLECULAR GENETICS (2006)
Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine
K Yokoi et al.
CLINICAL CANCER RESEARCH (2004)
Temporal control of NF-κB activation by ERK differentially regulates interleukin-1β-induced gene expression
BB Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4
F Marchesi et al.
CANCER RESEARCH (2004)
Pancreatic cancer biology and genetics
N Bardeesy et al.
NATURE REVIEWS CANCER (2002)
Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappa B
LV Madrid et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)